Federal grants to Ceria Therapeutics Inc
Ceria Therapeutics Inc in Tucson, Arizona received $8.4 million in federal grants from fiscal 2021 to 2025, across 5 awards. Its largest program was Military Medical Research and Development, with $3.8 million. In fiscal 2025 it was awarded $1.0 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$8.4 million
- Awards5
- Awarded in FY 2025$1.0 million
- Largest award$3.8 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 0 | $0 |
| FY 2022 | 2 | $598,520 |
| FY 2023 | 2 | $4.6 million |
| FY 2024 | 2 | $2.2 million |
| FY 2025 | 1 | $1.0 million |
Programs that fund Ceria Therapeutics Inc
| Program | Awards | Amount |
|---|---|---|
| Military Medical Research and Development | 1 | $3.8 million |
| Diabetes, Digestive, and Kidney Diseases Extramural Research | 2 | $2.3 million |
| Cardiovascular Diseases Research | 2 | $2.3 million |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 4 | $4.7 million |
| Department of Defense | 1 | $3.8 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Development of a field-use therapeutic for pulmonary injuries from trauma or chemical exposure | Military Medical Research and Development | September 22, 2023 | $3.8 million |
| A novel anti-inflammatoryand anti-oxidant therapy for treating non-healing diabetic foot ulcers - summary delayed or impaired wound healing is a serious complication of diabetes, often leading to lower limb amputations. By 2050, 1 in 3 americans will develop diabetes, and up to 34% of diabetic patie | Diabetes, Digestive, and Kidney Diseases Extramural Research | January 15, 2024 | $2.0 million |
| Targeting inflammation and oxidative stress to treat acute lung injury with CNP-MIR146A - summary acute respiratory distress syndrome (ARDS) accounts for 10% of icu admissions worldwide, with a mortality as high as 46%. Ards incidence has risen dramatically during the COVID-19 pandemic. Despite impr | Cardiovascular Diseases Research | September 15, 2023 | $2.0 million |
| Targeting inflammation and oxidative stress to treat acute lung injury with CNP-MIR146A - project summary - acute respiratory distress syndrome (ARDS) accounts for 10% of icu admissions worldwide with a mortality as high as 46%. This incidence has risen dramatically in the last year due to the novel | Cardiovascular Diseases Research | March 21, 2022 | $299,271 |
| A novel anti-inflammatory and anti-oxidant therapy for treating non-healing diabetic foot ulcers - project summary delayed or impaired wound healing is a serious complication of diabetes, often leading to lower limb ampu- tations. By 2050, 1 in 3 americans will develop diabetes, and up to 34% of dia | Diabetes, Digestive, and Kidney Diseases Extramural Research | September 16, 2022 | $299,249 |
Questions people ask
How much federal grant money does Ceria Therapeutics Inc get?
$8.4 million in 5 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Ceria Therapeutics Inc the most?
The Department of Health and Human Services, with $4.7 million in 4 awards. The Department of Defense follow.
What is Ceria Therapeutics Inc's largest federal grant?
$3.8 million under Military Medical Research and Development, with its first action in the period on September 22, 2023. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Ceria Therapeutics Inc?
Its largest are Military Medical Research and Development, Diabetes, Digestive, and Kidney Diseases Extramural Research and Cardiovascular Diseases Research.
Other grant recipients in Tucson
- University of Arizona
- Association of Universities for Research in Astronomy, Inc.
- City of Tucson
- Tucson Airport Authority Inc
- Child-Parent Centers, Inc.
- Visionquest National LTD
- SOUTH32 Hermosa Inc
- Pascua Yaqui Tribe
Largest federal grant recipients in Arizona · Federal grants in Arizona